Skip to main content
NVDA-0.42%AAPL-1.51%GOOGL+0.97%MSFT+2.16%AMZN+2.51%TSM-1.47%SPCX+0.35%META-0.14%AVGO+0.66%TSLA+2.05%SKHY-0.02%MU-0.40%BRK-B+0.83%LLY+0.71%AMD-1.52%JPM+0.45%WMT+0.50%V+2.50%XOM+0.27%ASMLa-1.84%JNJ+1.90%INTC-1.42%MA+2.01%0700.HK+3.26%ABBV+1.69%CSCO+2.57%1398.HK-0.92%CVX+0.44%COST-0.25%AMAT-0.24%AP2d-2.02%ORCL+4.37%LRCX-0.04%DELL+1.22%BAC+0.98%KO+0.48%CAT+0.89%PG+0.49%UNH+2.16%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.42%PM-0.14%0857.HK0.00%0939.HK+0.83%NFLX-1.63%MS+1.10%1288.HK-1.52%NZDMXN+1.68%USDMXN+1.60%EURAUD-0.88%AUDJPY+0.65%AUDCHF+0.61%EURUSD-0.55%USDPLN+0.54%EURZAR-0.50%CHFSEK+0.48%AUDCAD+0.48%GBPAUD-0.46%AUDDKK+0.46%EURGBP-0.45%EURNZD-0.44%AUDNZD+0.44%USDTRY+0.43%GBPTRY+0.41%EURCAD-0.40%EURCHF-0.36%EURPLN+0.35%AUDUSD+0.34%AUDSGD+0.33%AUDNOK+0.33%EURCNH-0.33%USDSEK+0.33%GBPHKD+0.32%GBPZAR-0.32%USDZAR-0.31%EURJPY-0.30%GBPMXN-0.28%PLNJPY-0.28%USDJPY+0.28%CHFSGD+0.21%CHFNOK+0.20%SGDJPY+0.20%USDCHF+0.20%NOKJPY+0.19%EURHKD-0.19%USDDKK+0.18%NZDJPY+0.18%GBPJPY+0.17%USDILS+0.16%USDCNH-0.16%USDCAD+0.15%EURNOK-0.14%EURSEK+0.14%NZDSGD+0.14%EURSGD-0.13%CADJPY+0.12%GBPCHF+0.10%NZDCHF+0.10%NZDUSD-0.10%GBPUSD-0.09%EURCZK+0.08%CHFJPY+0.07%GBPCAD+0.06%NZDCAD+0.06%USDSGD+0.05%GBPSGD+0.05%USDNOK+0.05%CADCHF+0.04%USDCOP-0.04%USDTHB-0.01%USDHKD+0.01%GBPNZD+0.01%EURDKK-0.01%C1-4.65%XNGUSD+3.56%GAGUSD+2.65%XAGUSD+2.65%XPTUSD+2.64%HG1+2.29%W1-2.14%GAUUSD+1.47%XAUUSD+1.47%S1-0.73%COTTON+0.69%USOIL+0.37%BTCUSD+1.20%ETHUSD+16.31%USDTUSD+0.01%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT+0.03%ZECUSDT+2.66%DOGEUSD+11.60%XMRUSDT-3.16%LINKUSD+12.58%XLMUSD+0.65%BCHUSDT+1.40%LTCUSD+5.93%UNIUSD+3.07%SUIUSD+2.31%HBARUSDT+0.22%TONUSD+24.22%TAOUSDT+2.54%AAVEUSD+2.07%DOTUSDT+10.38%ICPUSDT+4.40%ONDOUSDT+2.04%WLDUSDT+2.86%JUPUSDT+12.24%ARBUSDT+4.26%ATOMUSDT+13.72%INJUSDT+2.90%STXUSDT+0.16%FETUSDT+0.51%PYTHUSDT+1.12%SEIUSDT+0.62%TIAUSDT-5.69%IMXUSDT+0.33%GRTUSDT+3.32%OPUSDT+4.67%IOTAUSDT+0.76%WIFUSDT+1.64%AXSUSDT+1.16%POLUSDT+2.71%FARTCOINUSDT-0.96%EOSUSDT+4.52%DYDXUSDT+5.75%GALAUSDT+1.47%ORDIUSDT+0.81%RONINUSDT+2.73%NOTUSDT+3.72%NVDA-0.42%AAPL-1.51%GOOGL+0.97%MSFT+2.16%AMZN+2.51%TSM-1.47%SPCX+0.35%META-0.14%AVGO+0.66%TSLA+2.05%SKHY-0.02%MU-0.40%BRK-B+0.83%LLY+0.71%AMD-1.52%JPM+0.45%WMT+0.50%V+2.50%XOM+0.27%ASMLa-1.84%JNJ+1.90%INTC-1.42%MA+2.01%0700.HK+3.26%ABBV+1.69%CSCO+2.57%1398.HK-0.92%CVX+0.44%COST-0.25%AMAT-0.24%AP2d-2.02%ORCL+4.37%LRCX-0.04%DELL+1.22%BAC+0.98%KO+0.48%CAT+0.89%PG+0.49%UNH+2.16%3988.HK+1.66%1816.HK+0.45%0005.HK+1.82%HSBA.L+1.10%GE+0.42%PM-0.14%0857.HK0.00%0939.HK+0.83%NFLX-1.63%MS+1.10%1288.HK-1.52%NZDMXN+1.68%USDMXN+1.60%EURAUD-0.88%AUDJPY+0.65%AUDCHF+0.61%EURUSD-0.55%USDPLN+0.54%EURZAR-0.50%CHFSEK+0.48%AUDCAD+0.48%GBPAUD-0.46%AUDDKK+0.46%EURGBP-0.45%EURNZD-0.44%AUDNZD+0.44%USDTRY+0.43%GBPTRY+0.41%EURCAD-0.40%EURCHF-0.36%EURPLN+0.35%AUDUSD+0.34%AUDSGD+0.33%AUDNOK+0.33%EURCNH-0.33%USDSEK+0.33%GBPHKD+0.32%GBPZAR-0.32%USDZAR-0.31%EURJPY-0.30%GBPMXN-0.28%PLNJPY-0.28%USDJPY+0.28%CHFSGD+0.21%CHFNOK+0.20%SGDJPY+0.20%USDCHF+0.20%NOKJPY+0.19%EURHKD-0.19%USDDKK+0.18%NZDJPY+0.18%GBPJPY+0.17%USDILS+0.16%USDCNH-0.16%USDCAD+0.15%EURNOK-0.14%EURSEK+0.14%NZDSGD+0.14%EURSGD-0.13%CADJPY+0.12%GBPCHF+0.10%NZDCHF+0.10%NZDUSD-0.10%GBPUSD-0.09%EURCZK+0.08%CHFJPY+0.07%GBPCAD+0.06%NZDCAD+0.06%USDSGD+0.05%GBPSGD+0.05%USDNOK+0.05%CADCHF+0.04%USDCOP-0.04%USDTHB-0.01%USDHKD+0.01%GBPNZD+0.01%EURDKK-0.01%C1-4.65%XNGUSD+3.56%GAGUSD+2.65%XAGUSD+2.65%XPTUSD+2.64%HG1+2.29%W1-2.14%GAUUSD+1.47%XAUUSD+1.47%S1-0.73%COTTON+0.69%USOIL+0.37%BTCUSD+1.20%ETHUSD+16.31%USDTUSD+0.01%XRPUSD+8.70%SOLUSD+8.05%TRXUSDT+0.03%ZECUSDT+2.66%DOGEUSD+11.60%XMRUSDT-3.16%LINKUSD+12.58%XLMUSD+0.65%BCHUSDT+1.40%LTCUSD+5.93%UNIUSD+3.07%SUIUSD+2.31%HBARUSDT+0.22%TONUSD+24.22%TAOUSDT+2.54%AAVEUSD+2.07%DOTUSDT+10.38%ICPUSDT+4.40%ONDOUSDT+2.04%WLDUSDT+2.86%JUPUSDT+12.24%ARBUSDT+4.26%ATOMUSDT+13.72%INJUSDT+2.90%STXUSDT+0.16%FETUSDT+0.51%PYTHUSDT+1.12%SEIUSDT+0.62%TIAUSDT-5.69%IMXUSDT+0.33%GRTUSDT+3.32%OPUSDT+4.67%IOTAUSDT+0.76%WIFUSDT+1.64%AXSUSDT+1.16%POLUSDT+2.71%FARTCOINUSDT-0.96%EOSUSDT+4.52%DYDXUSDT+5.75%GALAUSDT+1.47%ORDIUSDT+0.81%RONINUSDT+2.73%NOTUSDT+3.72%
CL

Caris Life Sciences, Inc. (CAI)

NASDAQ • Healthcare

$27.5
+$0.39 (+1.5%)
Market open

Last close at October 8, 2026 at 20:00 UTC

Open$26.75
Previous Close$27.5
Day Range$25.87 - $27.62
Avg. Volume (3M)5M
Market Cap$8.1B
P/E Ratio74.3
52 Week Range
$14.19$33.65
Next EarningsIn 26 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$263.7M100%
Gross Profitminus cost of goods$179.5M68%
Operating Incomeminus R&D and overhead$26.9M10%

Fundamentals & Financials

Revenue (TTM)
$989.6M
Net Income (TTM)
$105.1M
EPS (TTM)
$0.37
ROA (TTM)
8.55%
Current Ratio
5.53
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2700.0%Q1 2026$0.28
+91.0%Q2 2026$0
-139.2%Q3 2026$0
Next

Nov 4

in 26 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -139.2%

Caris Life Sciences’ revenue topped consensus as sales rose 45.4% to about $263.7 million in the second fiscal quarter of 2026 (period ended June 30, 2026), based on preliminary results reported August 5, 2026. Revenue of $263.7 million topped the $238.1 million estimate, +10.8%, and was up from about $181.4 million a year ago, with the company’s molecular profiling and oncology-focused diagnostics platform (including MI Profile and Caris Assure) underpinning the quarter’s scale. Profitability tracked higher volume, with gross profit of roughly $179.6 million translating to a gross margin of about 68%, while operating income came in near $26.9 million and operating margin stood around 10%. Cash generation was also positive, as Caris produced operating cash flow of about $61.4 million, and it repurchased roughly $21.4 million of stock during the period. Consensus for the next period calls for EPS of $0.02 on revenue of $255.5 million.

Next report — what to expect

Caris Life Sciences, Inc. (CAI) reports on November 4, 2026. Wall Street is looking for EPS of $0.03 on revenue of $256.3 million. For trailing context, revenue grew +45.4% year over year last quarter. The company has beaten EPS in 5 of its 8 most recent quarters.

View full earnings history

About Caris Life Sciences, Inc.

Caris Life Sciences, Inc. develops molecular diagnostics and research tools for oncology, operating in healthcare and biotechnology and trading on the NASDAQ as CAI. Its platform analyzes tumor and blood samples to guide cancer treatment and support drug development, and it generated $812.0 million in revenue in FY2025.

Name
Caris Life Sciences, Inc.
CEO
David Dean Halbert
Website
www.carislifesciences.com
Industry
Healthcare
Year Founded
2008
Employees
1,846

Today's Snapshot

AI-generated

CAI is trading 6% above yesterday's close, in line with a firmer sector. Bank of America analysts upgraded Caris Life Sciences.

Trading Volume

Below 10d avg (3.8M)

1.6M

vs S&P 500 Today

Strong Outperformance

+5.49%

Updated: October 9, 2026 at 16:53 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
CAI's technicals show a bullish orientation driven by a strong trend reading (ADX above 35) and price positioned above most medium- and long-term moving averages, which supports a longer-term constructive view. Momentum and MACD are mixed-to-neutral and oscillators sit in the middle of their ranges, while ATR is relatively high on a percentage basis, implying active price swings. Notably, on‑balance volume is negative, a countervailing signal that tempers the bullish picture, yet the classic pivot at 27.00 lies well below the current price and provides an immediate support reference. Technical takeaway: Strong Buy — trend strength and moving-average alignment underpin the bullish stance.
All signals
  • EMA (5 indicators)$23.52 - $28.85
    Buy
  • RSI (14)54.08
    Neutral
  • Stochastic %K (14, 3, 3)28.25
    Neutral
  • MACD Level (12, 26)0.73
    Neutral

Peers & Related Assets

ADPTAdaptive Biotechnologies Corporation
$26.09-0.7%
WGSGeneDx Holdings Corp.
$67.73-1.2%
CSTLCastle Biosciences, Inc.
$33.71+2.1%
NEONeoGenomics, Inc.
$16.02+0.3%
PSNLPersonalis, Inc.
IMDXInsight Molecular Diagnostics Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.